241. Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration

242. Dexamethasone intravitreal implant in diabetic macular edema: real-life data from a prospective study and predictive factors for visual outcome

243. Ocular gene therapy for neovascular AMD: a new era?

244. Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema

245. Anti-platelet effects of vitamin supplements in age-related macular degeneration: an in vitro study

246. The role of glycemic control and variability in diabetic retinopathy

247. Internal limiting membrane peeling in macular hole surgery; why, when, and how?

248. Chronic central serous chorioretinopathy-like maculopathy as atypical presentation of chorioretinal folds

249. Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration

250. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension

251. Viscoat Versus Visthesia During Phacoemulsification Cataract Surgery: Corneal And Foveal Changes

252. Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy

253. Psychological aspects and depression in patients with symptomatic keratoconus

254. Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes

255. Editorial-suboptimal response to intravitreal anti-VEGF treatment for patients with diabetic macular edema: is there any point in switching treatment

256. Optic disk pit maculopathy: current management strategies

257. Current and emerging treatment modalities for Leber’s hereditary optic neuropathy: a review of the literature

258. Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature

259. Angioid streaks: a comprehensive review from pathophysiology to treatment

260. Fundus autofluorescence changes in diabetic retinopathy